Citing the virus threat, Russian cities have refused to hold June 24 celebrations of the Soviet Union’s victory over the Nazis. President Trump’s campaign is requiring rally audiences to agree not to sue if they contract Covid-19. View original article Contributor:
“This is the dreaded question,” say experts struggling to weigh virus risks and uncertainty against family well-being. View original article Contributor:
Did you follow the headlines this week? View original article Contributor:
When Dr. Anthony Fauci said in late May that there’s a “good chance” a COVID-19 vaccine will be ready by the end of this year, Steve Roth badly wanted to believe him. Roth, a 74-year-old New Yorker who endured fever, pneumonia and anxiety while fighting the virus, wants life to go back to normal as … Read more
Surgeons in Chicago have given a new set of lungs to a young woman with severe lung damage from the coronavirus. Northwestern Medicine on Thursday announced the procedure, which took place last Friday. Only a few other COVID-19 survivors, in China and Europe, have received lung transplants. The Chicago patient is in her 20s and … Read more
When COVID-19 began spreading in the U.S., Dan Kerber was drawn to the data. The 48-year-old from Plano, Texas read about case counts and projections every day, keeping his team at the telecommunications company Ericsson up to date on the latest news. So in May, when states including Texas began to reopen before the data … Read more
Dr. Francis Collins is a geneticist, former head of the Human Genome Project and the current director of the National Institutes of Health, the government agency primarily responsible for health research in the United States. In May, he joined the White House Coronavirus Taskforce. He also won the Templeton Prize, a $1.3 million prize for … Read more
On June 11, biotech company Moderna announced it had finalized plans for phase 3 testing of its COVID-19 vaccine candidate. The late-stage trial will include 30,000 participants and is expected to begin in July. The trial will test just one dose level of the vaccine, 100 micrograms, given in two shots. In the earlier phase … Read more
At the dawn of the pandemic, as businesses shuttered and frontline workers braved inadequate conditions and the death toll began to tick frighteningly upward, I was home alone, nursing one selfish obsession: that I would use this time to get in really good shape. I am not proud of this–I would much rather write that … Read more
The old vaccines are oddities among the cutting-edge and targeted technologies being developed to combat the novel coronavirus. View original article Contributor: Carolyn Y. Johnson